{
  "id": "adv_mhgap#management_ed19d6fc",
  "content": "S0033291720001610).\nH, Hoare Z et al. Maintenance cognitive\nstimulation therapy: an economic evaluation 136. Lewis G, Marston L, Duffy L, Freemantle N, Gilbody\nwithin a randomized controlled trial. J Am Med Dir S, Hunter R et al. Maintenance or discontinuation\nAssoc. 2015;16(1):63–70 (https://doi.org/10.1016/j. of antidepressants in primary care. N Engl J Med.\njamda.2014.10.020). 2021;385(14):1257–67 (https://doi.org/10.1056/\nNEJMoa2106356).\n129. Cao B, Xu L, Chen Y, Wang D, Lee Y, Rosenblat JD\net al. Comparative efficacy of pharmacological 137. Cuijpers P, Quero S, Noma H, Ciharova M, Miguel C,\ntreatments on measures of self-rated functional Karyotaki E, et al. Psychotherapies for depression:\noutcomes using the Sheehan Disability Scale a network meta-analysis covering efficacy,\nin patients with major depressive disorder: a acceptability and long-term outcomes of all main\nsystematic review and network meta-analysis. treatment types. World Psychiatry. 2021;20(2):283–\nCNS Spectr. 2021;1–9 (https://doi.org/10.1017/ 93 (https://doi.org/10.1002/wps.20860).\nS1092852921000171).\n138. Karyotaki E, Efthimiou O, Miguel C, Bermpohl\n130. Cipriani A, Furukawa TA, Salanti G, Chaimani A, FMG, Furukawa TA, Cuijpers P et al. Internet-based\nAtkinson LZ, Ogawa Y et al. Comparative efficacy cognitive behavioral therapy for depression:\nand acceptability of 21 antidepressant drugs a systematic review and individual patient",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "work",
      "management"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General — Management S0033291720001610).\nH, Hoare Z et al. Maintenance cognitive\nstimulation therapy: an economic evaluation 136. Lewis G, Marston L, Duffy L, Freemantle N, Gilbody\nwithin a randomized controlled trial. J Am Med Dir S, Hunter R et al. Maintenance or discontinuation\nAssoc. 2015;16(1):63–70 (https://doi.org/10.1016/j. of antidepressants in primary care. N Engl J Med.\njamda.2014.10.020). 2021;385(14):1257–67 (https://doi.org/10.1056/\nNEJMoa2106356).\n129. Cao B, Xu L, Chen Y, Wang D, Lee Y, Rosenblat JD\net al. Comparative efficacy of pharmacological 137. Cuijpers P, Quero S, Noma H, Ciharova M, Miguel C,\ntreatments on measures of self-rated functional Karyotaki E, et al. Psychotherapies for depression:\noutcomes using the Sheehan Disability Scale a network meta-analysis covering efficacy,\nin patients with major depressive disorder: a acceptability and long-term outcomes of all main\nsystematic review and network meta-analysis. treatment types. World Psychiatry. 2021;20(2):283–\nCNS Spectr. 2021;1–9 (https://doi.org/10.1017/ 93 (https://doi.org/10.1002/wps.20860).\nS1092852921000171).\n138. Karyotaki E, Efthimiou O, Miguel C, Bermpohl\n130. Cipriani A, Furukawa TA, Salanti G, Chaimani A, FMG, Furukawa TA, Cuijpers P et al. Internet-based\nAtkinson LZ, Ogawa Y et al. Comparative efficacy cognitive behavioral therapy for depression:\nand acceptability of 21 antidepressant drugs a systematic review and individual patient S0033291720001610). h, hoare z et al."
}